Precision Therapeutics for NF1-Associated Tumors: Improved Outcomes Through Targeted MEK Inhibition

Precision Therapeutics for NF1-Associated Tumors: Improved Outcomes Through Targeted MEK Inhibition

Ondemand webcast of expert faculty presentation and case discussion on precision therapeutic strategies to treat patients with NF1associated tumorsimproving outcomes through use of targeted MEK inhibition

  • Provider:Clinical Care Options
  • Activity Link: https://clinicaloptions.com/CE-CME/oncology/precision-therapeutics-in-nf1-associated-tumors/30948-69212
  • Start Date: 2024-12-24 06:00:00
  • End Date: 2024-12-24 06:00:00
  • Credit Details: IPCE Credits: 1.0 hours
    AAPA Category 1 Credit™️: 1.0 hours
    AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • Commercial Support: Source: Alexion Pharmaceuticals - Amount: 142500.0 - Is Kind Support: False Source: Springworks Therapeutics Inc - Amount: 12500.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.